Convertible bond

Medalist Diversified REIT Announces Private Placement of up to $5.0 Million of Convertible Debentures

Wednesday, October 28, 2020 - 8:46pm

The private placement of such convertible debentures is subject to customary closing conditions.

Key Points: 
  • The private placement of such convertible debentures is subject to customary closing conditions.
  • Kingswood Capital Markets, division of Benchmark Investments, Inc., acted as the exclusive placement agent for the transaction.
  • The convertible debentures to be issued to the Purchaser bear interest at a rate of 5% per year.
  • Medalist Diversified REIT Inc. is a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Mid-Atlantic and Southeast regions.

Delay interest payment of convertible bonds

Friday, October 23, 2020 - 11:02am

BCRE - Brack Capital Real Estate Investments N.V.

Key Points: 
  • BCRE - Brack Capital Real Estate Investments N.V.
    BCRE - Brack Capital Real Estate Investments N.V. announces that, due to the negative impact of COVID - 19, it delays the payment of the interest accrued on the Convertible bonds which was due on 20 September 2020.
  • The Company will publish an update by means of a press release with respect to the above matter.
  • BCRE - Brack Capital Real Estate Investments N.V.

Itasca Closes Previously Announced Capital Raise and Appoints Paul Rivett and Rick Doman to its Board

Thursday, October 22, 2020 - 9:00pm

Concurrently with the closing of the Private Placement, each of Mr. Paul Rivett and Rick Doman were appointed to Itasca's Board.

Key Points: 
  • Concurrently with the closing of the Private Placement, each of Mr. Paul Rivett and Rick Doman were appointed to Itasca's Board.
  • Each Unit is comprised of one Common Share and one Common Share purchase warrant of Itasca (a "Warrant").
  • Each Convertible Debenture is secured, and has a maturity date of two years from the date of issuance.
  • Prior to the purchases pursuant to the Private Placement neither Mr. Rivett nor Mr. Doman beneficially owned or controlled any Common Shares.

RegeneRx Closes Convertible Debt Financing

Wednesday, October 21, 2020 - 4:20pm

ROCKVILLE, Md., Oct. 21, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that it has completed a $500,000 convertible debt financing.

Key Points: 
  • ROCKVILLE, Md., Oct. 21, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that it has completed a $500,000 convertible debt financing.
  • The 5-year unregistered convertible notes carry a 5% simple interest rate that accrues during the term.
  • The note is convertible into 1,391,982 shares of RGRX common stock at $0.36 per share.
  • "This limited financing demonstrates continued support from our affiliates, management and board of directors, among others, and provides RegeneRx with essential funding with minimal dilution to our stockholders while we await the results of ARISE-3.

Recent Events Reinforce the Importance of Surface Sterilization

Tuesday, October 20, 2020 - 2:00pm

The research indicates that the increasing use of e-beam sterilization, rising importance of single-use medical nonwovens and medical devices are further increasing the demand for disinfection and sterilization products and services.

Key Points: 
  • The research indicates that the increasing use of e-beam sterilization, rising importance of single-use medical nonwovens and medical devices are further increasing the demand for disinfection and sterilization products and services.
  • PCT Ltd.(OTC: PCTL) just announced breaking news that, "it has received $400,000 in funding from California based RB Capital Partners, Inc. ("RB Capital").
  • RB Capital has provided funding to the Company in the form of two 12-month premium-to-market convertible notes.
  • Currently trading on OTC:PINK, "PCTL" is actively engaged in applying for listing its common stock to the OTC QB market.

Recent Events Reinforce the Importance of Surface Sterilization

Tuesday, October 20, 2020 - 2:00pm

The research indicates that the increasing use of e-beam sterilization, rising importance of single-use medical nonwovens and medical devices are further increasing the demand for disinfection and sterilization products and services.

Key Points: 
  • The research indicates that the increasing use of e-beam sterilization, rising importance of single-use medical nonwovens and medical devices are further increasing the demand for disinfection and sterilization products and services.
  • PCT Ltd.(OTC: PCTL) just announced breaking news that, "it has received $400,000 in funding from California based RB Capital Partners, Inc. ("RB Capital").
  • RB Capital has provided funding to the Company in the form of two 12-month premium-to-market convertible notes.
  • Currently trading on OTC:PINK, "PCTL" is actively engaged in applying for listing its common stock to the OTC QB market.

DGAP-News: PREOS Real Estate AG: further increase of the 7.50 % convertible bond by EUR 40.0 million

Friday, October 16, 2020 - 11:01am

Leipzig, 16.10.2020 - PREOS Real Estate AG (in future: PREOS Global Office Real Estate & Technology AG, "PREOS", ISIN DE000A2LQ850) has increased its 7.50% convertible bond (2019/2024, ISIN DE000A254NA6) by further partial debentures with a nominal value of EUR 40.0 million.

Key Points: 
  • Leipzig, 16.10.2020 - PREOS Real Estate AG (in future: PREOS Global Office Real Estate & Technology AG, "PREOS", ISIN DE000A2LQ850) has increased its 7.50% convertible bond (2019/2024, ISIN DE000A254NA6) by further partial debentures with a nominal value of EUR 40.0 million.
  • The outstanding volume of the PREOS convertible bond increases to a nominal EUR 219.4 million.
  • Overall, the convertible bond has a maximum volume of up to EUR 300 million.
  • Frederik Mehlitz, CEO of PREOS Real Estate AG, comments: "We are pleased about the additional financial resources that we will receive by placing a further tranche of our convertible bond.

DGAP-News: publity AG: further subscription of partial bonds of the PREOS Real Estate AG convertible bond with a nominal value of EUR 40.0 million.

Friday, October 16, 2020 - 11:01am

publity AG: further subscription of partial bonds of the PREOS Real Estate AG convertible bond with a nominal value of EUR 40.0 million.

Key Points: 
  • publity AG: further subscription of partial bonds of the PREOS Real Estate AG convertible bond with a nominal value of EUR 40.0 million.
  • publity AG: further subscription of partial bonds of the PREOS Real Estate AG convertible bond with a nominal value of EUR 40.0 million.
  • Frankfurt am Main, 16.10.2020 - publity AG (Scale, ISIN DE0006972508) has subscribed for a further tranche of bonds of the 7.50% convertible bond (ISIN DE000A254NA6) of its subsidiary PREOS Real Estate AG (in future: PREOS Global Office Real Estate & Technology AG, "PREOS", ISIN DE000A2LQ850) with a nominal value of EUR 40.0 million.
  • publity AG thus holds partial debentures of the PREOS convertible bond with a current nominal value of approximately EUR 182.2 million.

IntelGenx Closes U.S.$1.2 Million Private Placement Financing

Friday, October 16, 2020 - 12:38am

SAINT LAURENT, Quebec, Oct. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the Company or IntelGenx) announces the closing of an offering by way of private placement (the Offering) to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October15, 2024 (theNotes).

Key Points: 
  • SAINT LAURENT, Quebec, Oct. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the Company or IntelGenx) announces the closing of an offering by way of private placement (the Offering) to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October15, 2024 (theNotes).
  • IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.
  • Because these forward-looking statements are subject to a number of risks and uncertainties, IntelGenx' actual results could differ materially from those expressed or implied by these forward-looking statements.
  • Each of the TSX Venture Exchange and OTCQB has neither approved nor disapproved the contents of this press release.

Colabor Group Reports Results for the Third Quarter 2020

Thursday, October 15, 2020 - 10:10pm

Net debt corresponds to bank indebtedness, current portion of long-term debt, long-term debt and convertible debentures, net of cash.

Key Points: 
  • Net debt corresponds to bank indebtedness, current portion of long-term debt, long-term debt and convertible debentures, net of cash.
  • Consolidated sales for the third quarter amounted to $120.9 million compared to $165.8 million during the corresponding quarter of 2019, a decrease of 27.1%.
  • During the second quarter, the Company extended the maturity of its credit facility and subordinated debt which, combined with the results of the first three quarters of 2020, will allow Colabor to pursue its 2020 plan.
  • Despite the uncertainty surrounding the pandemic and its second wave, Colabor remains confident about the results for the coming months.